scispace - formally typeset
A

Alexandru Almasan

Researcher at Cleveland Clinic Lerner Research Institute

Publications -  111
Citations -  17838

Alexandru Almasan is an academic researcher from Cleveland Clinic Lerner Research Institute. The author has contributed to research in topics: Apoptosis & DNA damage. The author has an hindex of 48, co-authored 108 publications receiving 14896 citations. Previous affiliations of Alexandru Almasan include Cleveland Clinic Lerner College of Medicine & Howard Hughes Medical Institute.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy.

TL;DR: This review focuses on the apoptosis signaling pathways stimulated by Apo2L/TRAIL and summarizes what is known to date about the physiological role of this ligand and the potential for its application to cancer therapy.
Book ChapterDOI

Histone H2AX phosphorylation: a marker for DNA damage.

TL;DR: This chapter describes a few standard protocols that have been successfully used in the laboratory for a number of experimental systems, primarily hematologic and epithelial cells grown in culture.